Adapthealth ( (AHCO) ) has released its Q4 earnings. Here is a breakdown of the information Adapthealth presented to its investors.
AdaptHealth Corp., a prominent provider of healthcare-at-home solutions, offers services in the Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments, serving patients across the United States with a wide range of medical equipment and supplies.
AdaptHealth Corp. has released its financial results for the fourth quarter and full year of 2024, showcasing a modest increase in net revenue and a significant turnaround in net income compared to the previous year. The company also provided guidance for the fiscal year 2025.
For the full year 2024, AdaptHealth reported a net revenue increase of 1.9% to $3.26 billion and a net income of $90.4 million, a substantial improvement from the net loss of $678.9 million in 2023. Adjusted EBITDA rose by 2.7% to $688.7 million. The company also saw a rise in free cash flow to $235.8 million from $143.2 million. In the fourth quarter, despite a slight revenue decrease of 0.2%, the company achieved a net income of $50.3 million, reversing a loss from the previous year.
Looking ahead to 2025, AdaptHealth projects net revenue between $3.22 billion and $3.36 billion, with adjusted EBITDA expected to range from $670 million to $710 million. The company anticipates free cash flow between $180 million and $220 million.
AdaptHealth’s management remains optimistic about the future, focusing on initiatives such as the One Adapt program, AI and automation advancements, and strengthening their balance sheet, aiming to drive long-term growth and success.